Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2025 Mar;8(3):e70168.
doi: 10.1002/cnr2.70168.

Risk Factors for the Development of Barrett's Esophagus and Esophageal Adenocarcinoma: A Systematic Review and Meta-Analysis

Affiliations
Meta-Analysis

Risk Factors for the Development of Barrett's Esophagus and Esophageal Adenocarcinoma: A Systematic Review and Meta-Analysis

Kais Antonios et al. Cancer Rep (Hoboken). 2025 Mar.

Abstract

Background: Barrett's esophagus (BE) is the most widely established precursor to esophageal adenocarcinoma (EAC). Despite current screening guidelines, more than 90% of EAC patients lack a previous diagnosis of BE. We performed a systematic review and meta-analysis to identify the most important risk factors for the development of BE or EAC.

Recent findings: PubMed.gov, Ovid Medline, Embase, and Cochrane Library were searched through March 15, 2024. Studies comparing characteristics of patients with endoscopically diagnosed BE or EAC to control groups satisfied our inclusion criteria. Dual extraction provided data for random-effects meta-analyses. Sufficient data were extracted from 54 included studies to perform our meta-analyses. There were five risk factors with significant associations for the development of BE: symptoms of gastroesophageal reflux at least once weekly (OR, 3.56; 95% confidence interval [CI], 2.03-6.25; p = 0.004) tobacco smoking (OR, 1.41; 95% CI, 1.30-1.51; p < 0.001); alcohol use (OR, 1.37; 95% CI, 1.10-1.71; p = 0.008); male gender (OR, 1.36; 95% CI, 1.19-1.57; p < 0.001); and obesity (BMI > 30 kg/m2) (OR, 1.23; 95% CI, 1.09-1.39; p = 0.003). Tobacco smoking was significantly associated with the diagnosis of EAC (OR, 2.15; 95% CI, 1.85-2.43; p < 0.001).

Conclusion: Five risk factors showed significant associations with the development of BE and one with the development of EAC, with over a three-fold increase in BE for patients with gastroesophageal reflux more than once weekly. These data could prove useful in developing diagnostic paradigms with higher emphasis on patients experiencing more frequent acid reflux.

Keywords: Barrett's esophagus; cancer epidemiology; cancer screening; early detection; esophageal adenocarcinoma; gastroesophageal reflux.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

FIGURE 1
FIGURE 1
PRISMA flow diagram.
FIGURE 2
FIGURE 2
Forest plots for outcomes data. (A) Forest plot of pooled OR for male gender as a risk factor for being diagnosed with BE. (B) Forest plot of the pooled OR for male sex as a risk factor for being diagnosed with EAC. (C) Forest plot of the pooled OR for obesity as a risk factor with being diagnosed BE. (D) Forest plot of pooled OR for tobacco smoking as a risk factor for being diagnosed with BE. (E) Forest plot of pooled OR for tobacco smoking as a risk factor for being diagnosed with EAC. (F) Forest plot of pooled OR for reflux more than once weekly as a risk factor for being diagnosed with BE. (G) Forest plot of pooled OR for alcohol use as a risk factor for being diagnosed with BE. (H) Forest plot of pooled OR for alcohol use as a risk factor for being diagnosed with EAC.

References

    1. Coleman H. G., Xie S. H., and Lagergren J., “The Epidemiology of Esophageal Adenocarcinoma,” Gastroenterology 154, no. 2 (2018): 390–405. - PubMed
    1. Then E. O., Lopez M., Saleem S., et al., “Esophageal Cancer: An Updated Surveillance Epidemiology and End Results Database Analysis,” World Journal of Oncology 11, no. 2 (2020): 55–64. - PMC - PubMed
    1. Cook M. B. and Thrift A. P., “Epidemiology of Barrett's Esophagus and Esophageal Adenocarcinoma: Implications for Screening and Surveillance,” Gastrointestinal Endoscopy Clinics of North America 31, no. 1 (2021): 1–26. - PMC - PubMed
    1. Hur C., Miller M., Kong C. Y., et al., “Trends in Esophageal Adenocarcinoma Incidence and Mortality,” Cancer 119, no. 6 (2013): 1149–1158. - PMC - PubMed
    1. Domper Arnal M. J., Ferrández Arenas Á., and Lanas A. Á., “Esophageal Cancer: Risk Factors, Screening and Endoscopic Treatment in Western and Eastern Countries,” World Journal of Gastroenterology 21, no. 26 (2015): 7933–7943. - PMC - PubMed

MeSH terms

Supplementary concepts